Gene Therapy Manufacturing: US FDA Wants Academics Brought ‘Into The Loop’

FDA’s Peter Marks says educating academics about CMC would help them understand why it is necessary to do things in a standardized way. He predicts the field will move away from individual manufacturing platforms in the next five to 10 years.